SK
Samarth Kulkarni
DELAYED 1 MONTH
Director; Director, Chief Executive Officer
CRISPR Therapeutics AG
Oruka Therapeutics, Inc.
Filings
3
Companies
2
Latest
Jun 2, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
67
CRSPCLUSTER 4
CRISPR Therapeutics AG
Samarth Kulkarni
Director, Chief Executive Officer
Sale
$499.4K
10,349 sh
Mar 17 9:35 PM
Mar 16, 2026
—
CRISPR Therapeutics AG
Samarth Kulkarni
Director, Chief Executive Officer
Option Exercise
—
20,625 sh
Mar 17 9:35 PM
Mar 14, 2026
61
CRSPCLUSTER 2
CRISPR Therapeutics AG
Samarth Kulkarni
Director, Chief Executive Officer
Sale
$517.3K
9,798 sh
Mar 12 9:35 PM
Mar 11, 2026
—
CRISPR Therapeutics AG
Samarth Kulkarni
Director, Chief Executive Officer
Option Exercise
—
19,250 sh
Mar 12 9:35 PM
Mar 10, 2026